Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov version as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check21 days agoChange DetectedA banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.7%

- Check28 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe website footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision v3.7.0 was added and v3.6.6 was removed. This reflects an update to the record's version history rather than changes to the study data.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history page shows a new revision tag v3.6.6 replacing the previous v3.6.5. This change reflects an updated revision of the study record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.